CSO
Omnix Medical Ltd., Israel
Disclosure(s): No financial relationships to disclose
Dr. Niv Bachnoff has a PhD in Molecular and Structural Biochemistry from the Hebrew University of Jerusalem and is the major designer and developer of Omnix Medical’s Antimicrobial Peptides platform technology. The owner of several anti-infective related patents, he is an expert microbiologist and has vast experience in peptide-based drug design and the development of native-peptides for therapeutic applications.
Dr. Bachnoff is a co-founder and CSO at Omnix Medical and has been leading the R&D team in building Omnix unique peptide platform from early discovery stages and up to present clinical achievements. Dr. Bachnoff is responsible for all non-dilutive funding, resulting in securing over $13M from the European Innovation Commission, the United-States NIH, and the Israeli government.